Ovarian Cancer: New Protein Targets Identified
Proteins Identified to Improve Ovarian cancer treatment
Updated June 16, 2025
Scientists at Northeastern University have pinpointed proteins in ovarian cancer cells that could be targeted using photoimmunotherapy. This approach could allow for more precise and effective treatment of tumor cells, perhaps reducing harm to patients.
Photoimmunotherapy involves “lighting up” tumor cells so they are more visible, which could improve surgical precision.The technique may also prime surgical beds for follow-up chemotherapy and immunotherapy, potentially reducing the amount of drugs needed.
According to dr. Spring, a researcher involved in the study, the goal is to personalize medicine by tailoring treatment to each patient’s specific needs. This approach aims to avoid wasting resources and causing unnecessary harm.
“We want to do precision medicine where we find ways to look at each patient and tailor the treatment,” Spring said. “Otherwise, we’re just wasting resources, causing harm.”
Spring added that one of the primary goals of the research is to improve the quality of life for cancer patients by making treatments less grueling and reducing suffering.
What’s next
Further research will focus on refining photoimmunotherapy techniques and identifying additional cell surface targets to enhance the precision and effectiveness of ovarian cancer treatment.